AllergoOncology: evidence for safety and efficacy of a tumour-specific IgE antibody therapeutic candidate for ovarian cancer immunotherapy in the presence of soluble circulating tumour-associated antigen (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 71
Parent Publication: ALLERGY
ISSN: 0105-4538